Hyperphosphatemia Patients With Chronic Kidney Disease on 3x/Week Replacement Therapy

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Hyperphosphatemia Patients With Chronic Kidney Disease on 3x/Week Replacement Therapy trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

All recent trials (1 shown)

CompletedPhase 2

NCT00704483

Efficacy of SBR759 in Lowering Serum Phosphate Levels in Chronic Kidney Disease Patients on Hemodialysis

This study will evaluate the efficacy of SBR759 compared to sevelamer HCl in lowering serum phosphate levels in Chronic Kidney Disease patients on hemodialysis

United States321 participantsStarted 2008-07

Treatment: SBR759, Sevelamer HCl